Transforming growth factor (TGF)-β1 and TGF-β2 are growth and differentiation factors involved in EMT induction and regulation [31], which are upregulated in secretory endometrium from patients with adenomyosis [32,33,34], suggesting dysfunctionality during the secretory phase. This evidence concerns the gene TGFB2 and adenomyosis.